Randomised, double blind, placebo controlled trial of interferon, ribavirin, and amantadine versus interferon, ribavirin, and placebo in treatment naïve patients with chronic hepatitis C

Background and aim: In this study, we compared the efficacy of triple therapy (interferon alfa, ribavirin, and amantadine) with standard therapy (interferon alfa and ribavirin) in treatment naïve patients with chronic hepatitis C virus (HCV). Methods: In this prospective, randomised, double blind, p...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Thuluvath, P J, Maheshwari, A, Mehdi, J, Fairbanks, K D, Wu, L L-W, Gelrud, L G, Ryan, M J, Anania, F A, Lobis, I F, Black, M
Format: Artigo
Jezik:Inglês
Izdano: Copyright 2004 by Gut 2004
Teme:
Liver
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1773921/
https://ncbi.nlm.nih.gov/pubmed/14684587
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki